The Effect of γ-secretase Inhibitor Combined with BMSC on the aGVHD in Mice Model.
10.19746/j.cnki.issn.1009-2137.2021.03.045
- Author:
Yan WANG
1
;
Ban-Ban LI
1
;
Qing-Liang TENG
1
;
Zhao-Gang SUN
1
;
Shuang LIU
1
;
Chun-Pu LI
1
;
Hua MA
1
;
Dong-Mei GUO
2
Author Information
1. Department of Hematology, Taian City Central Hospital, Shandong First Medical University, Taian 271000, Shandong Province, China.
2. Department of Hematology, Taian City Central Hospital, Shandong First Medical University, Taian 271000, Shandong Province, China,E-mail: dongmeiguo@aliyun.com.
- Publication Type:Journal Article
- MeSH:
Amyloid Precursor Protein Secretases;
Animals;
Bone Marrow Transplantation;
Graft vs Host Disease;
Mice;
Mice, Inbred BALB C;
Mice, Inbred C57BL
- From:
Journal of Experimental Hematology
2021;29(3):937-943
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To establish the aGVHD mouse model，and investigate the regulatory effect and its mechanism of low-dose GSI combined with BMSC on aGVHD mice.
METHODS:C57BL/6 (H-2b) and BALB/c (H-2d) were selected as donor and recipient of allogeneic transplantation to establish the aGVHD mouse model. BALB/c mice were randomly divided into 6 groups, which were the bone marrow cell infusion after irradiation (BM) group; the bone marrow cells + spleen cells after irradiation (BM+SC) group; the bone marrow cells + spleen cells + DMSO (BM+SC+DMSO) (transplant control) group; bone marrow cells + splenocytes +GSI after irradiation (BM+SC+GSI) group; bone marrow cells + spleen cells + bone marrow mesenchymal stromal infusion after irradiation cell (BM+SC+BMSC) group; bone marrow cells + spleen cells + bone marrow mesenchymal stromal cells +GSI infused after irradiation (BM+SC+BMSC+GSI) group. The mice in the two groups containing GSI were intraperitoneally injected with GSI at 5 μmol/kg on day 1, 2, and 3 after transplantation with DMSO as a control. The general conditions, survival time and hematopoietic recovery of mice were observed, cytokines were detected by ELISA, and histopathological changes were detected by immunohistochemistry. The effects of low-dose GSI combined with BMSC on hematopoietic reconstruction and aGVHD development after allo-BMT were investigated.
RESULTS:The survival rate of the mice in BM+SC+BMSC+GSI combination group was 80% during the observation period, which was significantly higher than that in the other groups; the incidence of aGVHD was reduced in the BMSC GSI or their combination groups after 21 days of transplantation. GSI could partly promote the recovery of leukocytes, and show no significant delayed effect on the recovery platelets. Moreover, the level of Th1 cytokines (IFN-γ) in BM+SC+BMSC+GSI combined group was lower than that in BM+SC+GSI group (P<0.01), the level of Th2 cytokines (IL-4) in the combination group was higher than that in BM+SC+GSI group (P<0.01), also the level of IL-17 was significantly lower than that in the corresponding control group (P<0.001).
CONCLUSION:Low dose GSI combined with BMSC can promote hematopoietic reconstruction and regulate cytokines secretion including IFN-γ, IL-4 and IL-17. GSI combined with BMSC achieve the goal of synergistically inhibiting the occurrence and progression of aGVHD.
